Literature DB >> 1391977

Weight gain after primary surgery for breast cancer--effect of tamoxifen.

P J Hoskin1, S Ashley, J R Yarnold.   

Abstract

Changes in body weight have been studied in 92 consecutive patients with primary breast cancer from the time of initial diagnosis and treatment. Sixty patients receiving tamoxifen were compared with 32 controls receiving no hormone treatment. Weight gain was seen in both groups, but was greater in the group receiving tamoxifen. Premenopausal women receiving tamoxifen had greater weight gain than postmenopausal women on tamoxifen therapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1391977     DOI: 10.1007/bf01833342

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  10 in total

1.  Changes in body mass index in young adults in relation to number of life events experienced.

Authors:  M A Rookus; J Burema; J E Frijters
Journal:  Int J Obes       Date:  1988

2.  Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer.

Authors:  J K Camoriano; C L Loprinzi; J N Ingle; T M Therneau; J E Krook; M H Veeder
Journal:  J Clin Oncol       Date:  1990-08       Impact factor: 44.544

3.  Association of change in body mass with breast cancer.

Authors:  R Ballard-Barbash; A Schatzkin; P R Taylor; L L Kahle
Journal:  Cancer Res       Date:  1990-04-01       Impact factor: 12.701

4.  Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.

Authors: 
Journal:  N Engl J Med       Date:  1988-12-29       Impact factor: 91.245

5.  A placebo-controlled double-blind crossover investigation of the side effects attributed to oral contraceptives.

Authors:  J W Goldzieher; L E Moses; E Averkin; C Scheel; B Z Taber
Journal:  Fertil Steril       Date:  1971-09       Impact factor: 7.329

Review 6.  Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

7.  Oral medroxyprogesterone acetate in the treatment of metastatic breast cancer.

Authors:  G N Hortobagyi; A U Buzdar; D Frye; H Y Yap; V Hug; K Pinnamaneni; G Fraschini; H C Halvorson; G R Blumenschein
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

8.  Weight gain in adolescent and young adult oral contraceptive users.

Authors:  S Carpenter; L S Neinstein
Journal:  J Adolesc Health Care       Date:  1986-09

9.  Weight gain in women with localized breast cancer--a descriptive study.

Authors:  P J Goodwin; T Panzarella; N F Boyd
Journal:  Breast Cancer Res Treat       Date:  1988-04       Impact factor: 4.872

Review 10.  Tamoxifen therapy in primary breast cancer: biology, efficacy, and side effects.

Authors:  R R Love
Journal:  J Clin Oncol       Date:  1989-06       Impact factor: 44.544

  10 in total
  17 in total

1.  Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer.

Authors:  Lauren S Jammallo; Cynthia L Miller; Marybeth Singer; Nora K Horick; Melissa N Skolny; Michelle C Specht; Jean O'Toole; Alphonse G Taghian
Journal:  Breast Cancer Res Treat       Date:  2013-11       Impact factor: 4.872

Review 2.  Tamoxifen: a review of pharmacoeconomic and quality-of-life considerations for its use as adjuvant therapy in women with breast cancer.

Authors:  H M Bryson; G L Plosker
Journal:  Pharmacoeconomics       Date:  1993-07       Impact factor: 4.981

3.  Change in lifestyle behaviors and medication use after a diagnosis of ductal carcinoma in situ.

Authors:  Brian L Sprague; Amy Trentham-Dietz; Hazel B Nichols; John M Hampton; Polly A Newcomb
Journal:  Breast Cancer Res Treat       Date:  2010-04-02       Impact factor: 4.872

4.  Minimal limb volume change has a significant impact on breast cancer survivors.

Authors:  J N Cormier; Y Xing; I Zaniletti; R L Askew; B R Stewart; J M Armer
Journal:  Lymphology       Date:  2009-12       Impact factor: 1.286

5.  Determinants of Weight Gain During Adjuvant Endocrine Therapy and Association of Such Weight Gain With Recurrence in Long-term Breast Cancer Survivors.

Authors:  Akshara Raghavendra; Arup K Sinha; Janeiro Valle-Goffin; Yu Shen; Debu Tripathy; Carlos H Barcenas
Journal:  Clin Breast Cancer       Date:  2017-11-09       Impact factor: 3.225

6.  Identifying potential adverse effects using the web: a new approach to medical hypothesis generation.

Authors:  Adrian Benton; Lyle Ungar; Shawndra Hill; Sean Hennessy; Jun Mao; Annie Chung; Charles E Leonard; John H Holmes
Journal:  J Biomed Inform       Date:  2011-07-26       Impact factor: 6.317

7.  Frailty in older breast cancer survivors: age, prevalence, and associated factors.

Authors:  Jill A Bennett; Kerri M Winters-Stone; Jessica Dobek; Lillian M Nail
Journal:  Oncol Nurs Forum       Date:  2013-05-01       Impact factor: 2.172

8.  Weight Changes in Black and White Women Receiving Chemotherapy Treatment for Breast Cancer.

Authors:  Vanessa B Sheppard; Chiranjeev Dash; Bridget Oppong; Lucile L Adams-Campbell
Journal:  J Clin Oncol Res       Date:  2015-03-12

9.  Compliance with national nutrition recommendations among breast cancer survivors in "stepping stone".

Authors:  Elizabeth A Dennis Parker; Vanessa B Sheppard; Lucile Adams-Campbell
Journal:  Integr Cancer Ther       Date:  2013-10-07       Impact factor: 3.279

10.  Weight change patterns among breast cancer survivors: results from the Shanghai breast cancer survival study.

Authors:  Kai Gu; Xiaoli Chen; Ying Zheng; Zhi Chen; Wei Zheng; Wei Lu; Xiao Ou Shu
Journal:  Cancer Causes Control       Date:  2009-12-31       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.